Literature DB >> 31404926

Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors.

Alexander C Egilman1, Audrey D Zhang2, Joshua D Wallach3, Joseph S Ross4.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31404926     DOI： 10.7326/M19-1085

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  1 in total

1.  Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review.

Authors:  Aaron S Long; Audrey D Zhang; Caitlin E Meyer; Alexander C Egilman; Joseph S Ross; Joshua D Wallach
Journal:  JAMA Netw Open       Date:  2021-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.